Literature DB >> 15830782

A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy.

Uwe Schneider1, Barbara Kaser-Hotz.   

Abstract

Estimates of secondary cancer risk after radiotherapy are becoming more important for comparative treatment planning. There is great uncertainty concerning the dose-response relationship for radiation-induced carcinogenesis at doses higher than 4 Gy. The purpose of this report is to determine a simple dose-response relationship for secondary cancer incidence after radiotherapy treatment which can be used for comparative treatment planning. In this report a simple one-parameter model to estimate the complication probability of secondary cancer was fitted to literature data on secondary cancer incidence after radiotherapy. The results showed a linear dose-response relationship in the low-dose part and an exponentially decreasing one after a maximum at around 10 Gy. The observed dose-response relationship and the literature data used to fit the dose-response indicate that cell death effects are important for the explanation of secondary cancer incidence. Even using a dose and dose-rate effectiveness factor (DDREF) of two (instead of one), a cancer incidence maximum is observed at around 10 Gy, with decreasing incidence at higher doses.

Entities:  

Mesh:

Year:  2005        PMID: 15830782     DOI: 10.1078/0939-3889-00242

Source DB:  PubMed          Journal:  Z Med Phys        ISSN: 0939-3889            Impact factor:   4.820


  23 in total

1.  Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.

Authors:  Laura A Rechner; Rebecca M Howell; Rui Zhang; Carol Etzel; Andrew K Lee; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2012-10-10       Impact factor: 3.609

2.  Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships.

Authors:  Uwe Schneider; Barbara Kaser-Hotz
Journal:  Radiat Environ Biophys       Date:  2005-11-05       Impact factor: 1.925

3.  Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.

Authors:  Charles B Simone; Kevin Kramer; William P O'Meara; Justin E Bekelman; Arnaud Belard; James McDonough; John O'Connell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-13       Impact factor: 7.038

4.  Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.

Authors:  Shunsuke Suzuki; Takahiro Kato; Masao Murakami
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

5.  Tumour size can have an impact on the outcomes of epidemiological studies on second cancers after radiotherapy.

Authors:  Uwe Schneider; Linda Walsh; Wayne Newhauser
Journal:  Radiat Environ Biophys       Date:  2018-08-31       Impact factor: 1.925

6.  Modification of p53 protein profile by gamma irradiation followed by methyl donor starvation.

Authors:  Vipen Batra; Vellappan Kesavan; Kaushala P Mishra
Journal:  Mol Cell Biochem       Date:  2006-06-09       Impact factor: 3.396

Review 7.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

8.  Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.

Authors:  Rui Zhang; Rebecca M Howell; Annelise Giebeler; Phillip J Taddei; Anita Mahajan; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2013-01-16       Impact factor: 3.609

9.  Risk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancer.

Authors:  Dong Wook Kim; Weon Kuu Chung; Dongoh Shin; Seongeon Hong; Sung Ho Park; Sung-Yong Park; Kwangzoo Chung; Young Kyung Lim; Dongho Shin; Se Byeong Lee; Hyun-Ho Lee; Myonggeun Yoon
Journal:  Radiat Oncol       Date:  2013-03-04       Impact factor: 3.481

10.  Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.

Authors:  Uwe Schneider; Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2007-12-21       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.